Table 8.

Lipid profile alterations indicative of dyslipidemia following the multidisciplinary interventions.

	Initial Assessment	Annual Assessment	p-Value
Cholesterol (≥200mg/dL)	221.23 ± 3.01	202.06 ± 4.22	<0.0001
LDL (≥130mg/dL)	142.33 ± 2	122.17 ± 3.02	<0.0001
ApoB (≥110 mg/dL)	130.16 ± 3.17	97.87 ± 4.61	<0.0001
Triglycerides
0–9 age (≥100 mg/dL)	130.60 ± 4.83	100.79 ± 5.70	<0.0001
10–19 age (≥130 mg/dL)	174.68 ± 5.68	125.34 ± 7.77	<0.0001
HDL (<40 mg/dL)	35.39 ± 0.30	41.61 ± 0.74	<0.0001
ApoA1 (<115 mg/dL)	95.36 ± 7.70	99.36 ± 1.59	0.629
Lp(a) (>30 mg/dL)	58.77 ± 2.09	57.68 ± 2.90	0.113

Abbreviations: ApoA1: Apolipoprotein A1, ApoB: Apolipoprotein B, HDL: High-Density Lipoprotein, LDL: Low-Density Lipoprotein, Lp(a): Lipoprotein a.